{"id":"W2801876087","doi":"10.1097/coc.0000000000000451","title":"Nivolumab in the Treatment of Metastatic Renal Cell Carcinoma","year":2018,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Princess Margaret Cancer Centre; Public Health Ontario; University of Toronto; Sunnybrook Health Science Centre; Western University","funders":"","keywords":"Nivolumab; Medicine; Renal cell carcinoma; Quality-adjusted life year; Willingness to pay; Cost effectiveness; Oncology; Cost–utility analysis; Everolimus; Cost–benefit analysis; Cohort; Quality of life (healthcare); Internal medicine; Cancer; Intensive care medicine; Immunotherapy; Risk analysis (engineering); Nursing","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001154604,0.0002079434,0.0003108025,0.0002406218,0.0001622272,0.0005066364,0.0003646641,0.0003115367,0.001313957],"category_scores_gemma":[0.001972571,0.00009696873,0.0007331012,0.0002703758,0.0001676964,0.0001738108,0.0002098181,0.0004638422,0.00009680529],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003773124,"about_ca_system_score_gemma":0.003485088,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04841716,"about_ca_topic_score_gemma":0.08806483,"domain_scores_codex":[0.999438,0.0003248962,0.00001876422,0.00003716169,0.0001344398,0.00004686719],"domain_scores_gemma":[0.9996194,0.0002086535,0.0000688504,0.00001384094,0.00005744464,0.00003185507],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.01540302,0.0008718888,0.05484029,0.003095451,0.00367529,0.0009955715,0.0001105776,0.4645289,0.009345044,0.007488698,0.01527474,0.4243704],"study_design_scores_gemma":[0.01119286,0.01262771,0.1411767,0.003593409,0.007109585,0.004027219,0.0002809612,0.6215716,0.02548425,0.0214584,0.1512226,0.000254801],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8494745,0.1071162,0.009347784,0.006514923,0.0003913148,0.000762109,0.001888577,0.0001557922,0.02434873],"genre_scores_gemma":[0.9910975,0.005711334,0.001372817,0.0004059304,0.00005755011,0.00005411161,0.0002713105,0.000006629396,0.00102292],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04841716,"threshold_uncertainty_score":0.09627068,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1069168412521974,"score_gpt":0.4359489687321487,"score_spread":0.3290321274799514,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}